Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Robert Page to Heart Failure

This is a "connection" page, showing publications Robert Page has written about Heart Failure.

 
Connection Strength
  
 
 
4.332
  
  1. Ilonze OJ, Helmkamp LJ, McIlvennan CK, Allen LA, Breathett K, Enyi CO, Page RL. Trends in urine drug screening and positivity among patients with heart failure: Insights from a large health system. Am Heart J. 2025 Dec; 290:226-229.
    View in: PubMed
    Score: 0.349
  2. Page RL, Chow SL. Polypharmacy and the Clinical Inertia Conundrum for GDMT. JACC Heart Fail. 2023 11; 11(11):1518-1520.
    View in: PubMed
    Score: 0.309
  3. Schoenborn EM, Skersick PT, Thrasher CM, Page RL. Expanded use of sodium-glucose cotransporter 2 inhibitors: Evidence beyond heart failure with reduced ejection fraction. Pharmacotherapy. 2023 09; 43(9):950-962.
    View in: PubMed
    Score: 0.303
  4. Page RL. The Real-World Price of Switching to an ARNI: A Case for De Novo Sacubitril/Valsartan Initiation. J Am Coll Cardiol. 2023 01 31; 81(4):332-335.
    View in: PubMed
    Score: 0.295
  5. Page RL, Allen LA. Cocaine, Heart Failure, and Carvedilol: Triangulating the Safety of ß-Blocker Therapy. JACC Heart Fail. 2019 09; 7(9):779-781.
    View in: PubMed
    Score: 0.233
  6. Page RL, Lindenfeld J. Ground Hog Day: Do We Need Another Analysis of Diuretic Dose and Outcomes in Heart Failure Patients? J Card Fail. 2017 08; 23(8):594-596.
    View in: PubMed
    Score: 0.199
  7. McIlvennan CK, Page RL. Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part II. J Cardiovasc Nurs. 2016 Nov/Dec; 31(6):545-554.
    View in: PubMed
    Score: 0.191
  8. Page RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J. Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016 Aug 09; 134(6):e32-69.
    View in: PubMed
    Score: 0.187
  9. Paul S, Page RL. Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part I. J Cardiovasc Nurs. 2016 Mar-Apr; 31(2):101-13.
    View in: PubMed
    Score: 0.183
  10. Kao DP, Lindenfeld J, Macaulay D, Birnbaum HG, Jarvis JL, Desai US, Page RL. Impact of a Telehealth and Care Management Program on All-Cause Mortality and Healthcare Utilization in Patients with Heart Failure. Telemed J E Health. 2016 Jan; 22(1):2-11.
    View in: PubMed
    Score: 0.175
  11. Ghushchyan V, Nair KV, Page RL. Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both. Vasc Health Risk Manag. 2015; 11:25-34.
    View in: PubMed
    Score: 0.168
  12. Wiggins BS, Rodgers JE, DiDomenico RJ, Cook AM, Page RL. Discharge counseling for patients with heart failure or myocardial infarction: a best practices model developed by members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network based on the Hospital to Home (H2H) Initiative. Pharmacotherapy. 2013 May; 33(5):558-80.
    View in: PubMed
    Score: 0.149
  13. Page RL, Lindenfeld J. The comorbidity conundrum: a focus on the role of noncardiovascular chronic conditions in the heart failure patient. Curr Cardiol Rep. 2012 Jun; 14(3):276-84.
    View in: PubMed
    Score: 0.141
  14. Page RL, Cantu M, Lindenfeld J, Hergott LJ, Lowes BD. Possible heart failure exacerbation associated with pregabalin: case discussion and literature review. J Cardiovasc Med (Hagerstown). 2008 Sep; 9(9):922-5.
    View in: PubMed
    Score: 0.109
  15. Page RL, Ferguson D, Cantu M. An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure. Cardiology. 2008; 110(2):112-5.
    View in: PubMed
    Score: 0.102
  16. Dunlay SM, Colvin M, Cowger JA, Crespo Leiro MG, Desai AS, Greene SJ, Gustafsson F, Hall S, Ilonze OJ, Lala A, Lam CSP, Page RL, Lund LH, McDonagh TA, McIlvennan CK, Pinney SP, Truby LK, Yancy CW, Bozkurt B, Stevenson LW. Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position Statement. JACC Heart Fail. 2026 Jun; 14(6):103101.
    View in: PubMed
    Score: 0.093
  17. Lowe EF, Gerasta D, Balser M, Page RL, Tsai E, Biermann HD, Mitchell A, Chan D, Matlock DD, Dickert NW, Sloan CE, Allen LA. Contributors and Solutions to High Out-of-Pocket Costs for Heart Failure Medications: A State-of-the-Art Review. J Am Coll Cardiol. 2025 Feb 04; 85(4):365-377.
    View in: PubMed
    Score: 0.084
  18. Hollenberg SM, Stevenson LW, Ahmad T, Bozkurt B, Butler J, Davis LL, Drazner MH, Kirkpatrick JN, Morris AA, Page RL, Siddiqi HK, Storrow AB, Teerlink JR. 2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024 Sep 24; 84(13):1241-1267.
    View in: PubMed
    Score: 0.082
  19. Bozkurt B, Ahmad T, Alexander KM, Baker WL, Bosak K, Breathett K, Fonarow GC, Heidenreich P, Ho JE, Hsich E, Ibrahim NE, Jones LM, Khan SS, Khazanie P, Koelling T, Krumholz HM, Khush KK, Lee C, Morris AA, Page RL, Pandey A, Piano MR, Stehlik J, Stevenson LW, Teerlink JR, Vaduganathan M, Ziaeian B. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America. J Card Fail. 2023 10; 29(10):1412-1451.
    View in: PubMed
    Score: 0.077
  20. Page RL, Gozansky WS, Ruscin JM. Possible heart failure exacerbation associated with rosiglitazone: case report and literature review. Pharmacotherapy. 2003 Jul; 23(7):945-54.
    View in: PubMed
    Score: 0.076
  21. Sokos G, Kido K, Panjrath G, Benton E, Page R, Patel J, Smith PJ, Korous S, Guglin M. Multidisciplinary Care in Heart Failure Services. J Card Fail. 2023 06; 29(6):943-958.
    View in: PubMed
    Score: 0.074
  22. Morris A, Shah KS, Enciso JS, Hsich E, Ibrahim NE, Page R, Yancy C. The Impact of Health Care Disparities on Patients With Heart Failure. J Card Fail. 2022 07; 28(7):1169-1184.
    View in: PubMed
    Score: 0.070
  23. Boxer RS, Dolansky MA, Chaussee EL, Campbell JD, Daddato AE, Page RL, Fairclough DL, Gravenstein S. A Randomized Controlled Trial of Heart Failure Disease Management in Skilled Nursing Facilities. J Am Med Dir Assoc. 2022 03; 23(3):359-366.
    View in: PubMed
    Score: 0.066
  24. Sailer C, Edelmann H, Buchanan C, Giro P, Babcock M, Swanson C, Spotts M, Schulte M, Pratt-Cordova A, Coe G, Beindorff M, Page RL, Ambardekar AV, Pal JD, Kohrt W, Wolfel E, Lawley JS, Tarumi T, Cornwell WK. Impairments in Blood Pressure Regulation and Cardiac Baroreceptor Sensitivity Among Patients With Heart Failure Supported With Continuous-Flow Left Ventricular Assist Devices. Circ Heart Fail. 2021 01; 14(1):e007448.
    View in: PubMed
    Score: 0.064
  25. Allen LA, Venechuk G, McIlvennan CK, Page RL, Knoepke CE, Helmkamp LJ, Khazanie P, Peterson PN, Pierce K, Harger G, Thompson JS, Dow TJ, Richards L, Huang J, Strader JR, Trinkley KE, Kao DP, Magid DJ, Buttrick PM, Matlock DD. An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial. Circulation. 2021 02 02; 143(5):427-437.
    View in: PubMed
    Score: 0.063
  26. Venechuk GE, Khazanie P, Page RL, Knoepke CE, Helmkamp LJ, Peterson PN, Pierce K, Thompson JS, Huang J, Strader JR, Dow TJ, Richards L, Trinkley KE, Kao DP, McIlvennan CK, Magid DJ, Buttrick PM, Matlock DD, Allen LA. An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trial. Am Heart J. 2020 11; 229:144-155.
    View in: PubMed
    Score: 0.062
  27. Jackevicius CA, Page RL, Buckley LF, Jennings DL, Nappi JM, Smith AJ. Key Articles and Guidelines in the Management of Heart Failure: 2018 Update. J Pharm Pract. 2019 Feb; 32(1):77-92.
    View in: PubMed
    Score: 0.055
  28. Chow SL, Page RL, Depre C. Role of ivabradine and heart rate lowering in chronic heart failure: guideline update. Expert Rev Cardiovasc Ther. 2018 Jul; 16(7):515-526.
    View in: PubMed
    Score: 0.054
  29. Cobretti MR, Page RL, Linnebur SA, Deininger KM, Ambardekar AV, Lindenfeld J, Aquilante CL. Medication regimen complexity in ambulatory older adults with heart failure. Clin Interv Aging. 2017; 12:679-686.
    View in: PubMed
    Score: 0.049
  30. Bui QM, Allen LA, Monte AA, Page RL, McIlvennan CK. Amphetamine-positive urine drug screens in the setting of mexiletine use: A case series. J Heart Lung Transplant. 2016 08; 35(8):1045-8.
    View in: PubMed
    Score: 0.046
  31. McIlvennan CK, Page RL, Ambardekar AV, Brieke A, Lindenfeld J. Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients. J Heart Lung Transplant. 2014 Dec; 33(12):1312-4.
    View in: PubMed
    Score: 0.041
  32. Aquilante CL, Page RL, Vu A, Roscoe N, Wolfel EE, Lindenfeld JA. Comparison of office, home, and ambulatory blood pressure in heart transplant recipients. J Card Fail. 2014 Aug; 20(8):602-10.
    View in: PubMed
    Score: 0.040
  33. Milfred-Laforest SK, Chow SL, Didomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, Patterson JH, Vardeny O, Massie BM. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Card Fail. 2013 May; 19(5):354-69.
    View in: PubMed
    Score: 0.037
  34. Rohrer CK, Page RL, Shakar SF, Lindenfeld J. Carvedilol for the treatment of benign prostatic hypertrophy in patients with heart failure? J Card Fail. 2011 Oct; 17(10):875-7.
    View in: PubMed
    Score: 0.033
  35. Jackevicius CA, Page RL, Chow S, Dunn SP, Lee CR, Ng TM, Rodgers JE, Vardeny O, Wiggins BS, Munger MA. High-impact articles related to the management of heart failure: 2008 update. Pharmacotherapy. 2009 Jan; 29(1):82-120.
    View in: PubMed
    Score: 0.028
  36. Ilonze OJ, Knapp SM, Chernyak Y, Page RL, Boyd LJ, Mazimba S, Raman SV, Enyi CO, Allen LA, Breathett K. Cannabis use and heart transplant listing: A survey of clinician practices. PLoS One. 2024; 19(12):e0310778.
    View in: PubMed
    Score: 0.021
  37. Slatton ML, Irani WN, Hall SA, Marcoux LG, Page RL, Grayburn PA, Eichhorn EJ. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol. 1997 May; 29(6):1206-13.
    View in: PubMed
    Score: 0.012
  38. Connolly SJ, Schnell DJ, Page RL, Wilkinson WE, Marcello SR, Pritchett EL. Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation. Am J Cardiol. 2001 Nov 01; 88(9):974-9.
    View in: PubMed
    Score: 0.004
  39. Hamdan MH, Zagrodzky JD, Joglar JA, Sheehan CJ, Ramaswamy K, Erdner JF, Page RL, Smith ML. Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction. Circulation. 2000 Aug 29; 102(9):1027-32.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)